Joseph D. Morelle sold Allergan plc Ordinary Shares (AgN) [ST] F IlINg S TATuS : New D ESCRIPTION : ABBVIE, Inc. (ABBV) acquired the shares of AllERgAN (AgN). AgN shareholders received 0.866 ABBV in exchange for each share of AgN. (--)
Joseph D. Morelle (D-NY), a U.S. Representative, has disclosed 2 trades in Allergan plc Ordinary Shares (AgN) [ST] F IlINg S TATuS : New D ESCRIPTION : ABBVIE, Inc. (ABBV) acquired the shares of AllERgAN (AgN). AgN shareholders received 0.866 ABBV in exchange for each share of AgN. (--) since 2020, 1 purchase and 1 sale, worth an estimated $16K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Joseph D. Morelle sold $1,001 - $15,000 of Allergan plc Ordinary Shares (AgN) [ST] F IlINg S TATuS : New D ESCRIPTION : ABBVIE, Inc. (ABBV) acquired the shares of AllERgAN (AgN). AgN shareholders received 0.866 ABBV in exchange for each share of AgN. (--) on May 11, 2020. Since that trade, -- is up +0.00% against the S&P 500 up +179.62%, an outperformance of -179.62%.
Across these filings, Joseph D. Morelle has been a balanced trader of -- (a buy-to-sell ratio of 1.00). The most recent disclosed -- transaction shown was dated November 20, 2020. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Joseph D. Morelle's -- trades vs the price
-- is up +0.00% since Joseph D. Morelle sold on May 11, 2020, versus +179.62% for the S&P 500.
Performance since this trade
All Joseph D. Morelle -- trades
Joseph D. Morelle & -- trading FAQ
Is it legal for Joseph D. Morelle to trade Allergan plc Ordinary Shares (AgN) [ST] F IlINg S TATuS : New D ESCRIPTION : ABBVIE, Inc. (ABBV) acquired the shares of AllERgAN (AgN). AgN shareholders received 0.866 ABBV in exchange for each share of AgN. (--) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Allergan plc Ordinary Shares (AgN) [ST] F IlINg S TATuS : New D ESCRIPTION : ABBVIE, Inc. (ABBV) acquired the shares of AllERgAN (AgN). AgN shareholders received 0.866 ABBV in exchange for each share of AgN. (--), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Joseph D. Morelle sell --?
Joseph D. Morelle disclosed a sale of $1,001 - $15,000 of Allergan plc Ordinary Shares (AgN) [ST] F IlINg S TATuS : New D ESCRIPTION : ABBVIE, Inc. (ABBV) acquired the shares of AllERgAN (AgN). AgN shareholders received 0.866 ABBV in exchange for each share of AgN. (--) on May 11, 2020, according to public STOCK Act filings.
How has -- performed since Joseph D. Morelle's trade?
Since Joseph D. Morelle sold -- on May 11, 2020, the stock is up +0.00%, versus +179.62% for the S&P 500 over the same period, an outperformance of -179.62%.
How many times has Joseph D. Morelle traded --?
Joseph D. Morelle has disclosed 2 -- trades since 2020 (1 purchase and 1 sale). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional -- trades?
Quantellect tracks every disclosed congressional trade in Allergan plc Ordinary Shares (AgN) [ST] F IlINg S TATuS : New D ESCRIPTION : ABBVIE, Inc. (ABBV) acquired the shares of AllERgAN (AgN). AgN shareholders received 0.866 ABBV in exchange for each share of AgN. (--) on the Allergan plc Ordinary Shares (AgN) [ST] F IlINg S TATuS : New D ESCRIPTION : ABBVIE, Inc. (ABBV) acquired the shares of AllERgAN (AgN). AgN shareholders received 0.866 ABBV in exchange for each share of AgN. congressional trading page, which aggregates filings across all members of Congress.
Joseph D. Morelle's -- tradesAll congressional filings for Allergan plc Ordinary Shares (AgN) [ST] F IlINg S TATuS : New D ESCRIPTION : ABBVIE, Inc. (ABBV) acquired the shares of AllERgAN (AgN). AgN shareholders received 0.866 ABBV in exchange for each share of AgN.Joseph D. Morelle's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.